Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06178354 · ClinicalTrials.gov registry record · NA
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
A NA study of Stage II Prostate Cancer AJCC v8 and Stage I Prostate Cancer AJCC v8, sponsored by Marc Dall'Era, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06178354 is a NA study of Stage II Prostate Cancer AJCC v8 and Stage I Prostate Cancer AJCC v8 that is actively recruiting participants, run by Marc Dall'Era, MD. The registered enrollment target is 100 participants, below the 115-participant average among 21 other Stage II Prostate Cancer AJCC v8 trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06178354, a NA study of Stage II Prostate Cancer AJCC v8 and Stage I Prostate Cancer AJCC v8, is actively recruiting participants, sponsored by Marc Dall'Era, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the effectiveness of focal ablation with either focal cryotherapy or high intensity frequency ultrasound for the treatment of men with localized prostate cancer. Focal cryotherapy kills tumor cells by freezing them. High intensity frequency ultrasound uses highly focused ultrasound waves to produce heat and destroy tumor cells.
Conditions Studied
Interventions
- OTHER Survey Administration
- PROCEDURE Cryosurgery
- PROCEDURE High-Intensity Focused Ultrasound Ablation
Study Locations (1)
California
- University of California Davis Comprehensive Cancer Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-09 |
| Est. Completion | 2029-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06178354
The ClinicalTrials.gov registry entry for NCT06178354 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 115-participant average among 21 other Stage II Prostate Cancer AJCC v8 trials with a reported enrollment target (13% lower). The listed sponsor is Marc Dall'Era, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Stage II Prostate Cancer AJCC v8 appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT06178354 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06178354 about?
NCT06178354 is a clinical study titled "Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer". This clinical trial evaluates the effectiveness of focal ablation with either focal cryotherapy or high intensity frequency ultrasound for the treatment of men with localized prostate cancer. Focal cryotherapy kills tumor cells by freezing them. High intensity frequency ultrasound uses highly focuse...
What is the current status of trial NCT06178354?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-11-09. Estimated completion is 2029-06.
What conditions does trial NCT06178354 study?
This clinical trial studies the following conditions: Stage II Prostate Cancer AJCC v8, Stage I Prostate Cancer AJCC v8, Localized Prostate Carcinoma, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8.
What interventions are being tested in trial NCT06178354?
The interventions under investigation include: Survey Administration (OTHER), Cryosurgery (PROCEDURE), High-Intensity Focused Ultrasound Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT06178354?
This trial is sponsored by Marc Dall'Era, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06178354 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Prostate Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
RECRUITING · NA
-
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
RECRUITING · NA
-
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
RECRUITING · NA
-
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
RECRUITING · NA
-
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
RECRUITING · NA
-
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
RECRUITING · NA
Explore more on PlainTrial
Stage II Prostate Cancer AJCC v8
All registered trials for this condition
Stage I Prostate Cancer AJCC v8
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.